2026 NPPES data Medical Oncology Physician NPI 1740422039
Verify on CMS →

MELISSA ACCORDINO

Medical Oncology Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
280
Medicare Part D claims · 83 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$178.04
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MELISSA ACCORDINO reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 280 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
280
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MELISSA ACCORDINO's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MELISSA ACCORDINO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MELISSA ACCORDINO?

High performer (top quartile)

NPI registry status

Active

Issued 04/01/2009

NPI 1740422039

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

280 59% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Medical Oncology Physician compares to other specialties among New York providers

New York providers

Medical Oncology Physician share within New York

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within New York

Medicare quality performance — MIPS

MELISSA ACCORDINO's 2023 MIPS final score plotted against the Medical Oncology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MELISSA ACCORDINO appears in the CMS NPPES registry as a Medical Oncology Physician provider at 161 FORT WASHINGTON AVENUE, NEW YORK, NY, 10032, with a listed phone of (212) 305-9382. NPI 1740422039 was issued on 04/01/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ACCORDINO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 280 prescription claims written by this provider, covering 83 Medicare beneficiaries and totaling roughly $356K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 86.8066), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

161 FORT WASHINGTON AVENUE
NEW YORK, NY 10032

Provider Details

NPI 1740422039
Specialty Medical Oncology Physician
Gender Female
NPI Issued 04/01/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
86.8066
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MELISSA ACCORDINO bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
NEW YORK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MELISSA ACCORDINO. Source: openpaymentsdata.cms.gov.

Total received

$178

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MELISSA ACCORDINO. To verify MELISSA ACCORDINO's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MELISSA ACCORDINO — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 280 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

280
Total Claims
$356K
Total Drug Cost
83
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
426
Total Day Supply
12,006
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$344K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
1.45
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MELISSA ACCORDINO prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
92
Exemestane
55
Letrozole
39
Kisqali
Ribociclib Succinate
14
Tamoxifen Citrate
12
Prochlorperazine Maleate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How MELISSA ACCORDINO fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

MELISSA ACCORDINO's 280 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as ACCORDINO.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MELISSA ACCORDINO's specialty?
MELISSA ACCORDINO specializes in Medical Oncology Physician and practices in NEW YORK, New York.
How much does MELISSA ACCORDINO prescribe under Medicare Part D?
In 2023, MELISSA ACCORDINO wrote 280 Medicare Part D claims totaling $356K in drug costs for 83 beneficiaries.
What is MELISSA ACCORDINO's Medicare quality score?
MELISSA ACCORDINO has a CMS MIPS Final Score of 100/100 (Quality: 86.8066). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MELISSA ACCORDINO located?
MELISSA ACCORDINO is located at 161 FORT WASHINGTON AVENUE, NEW YORK, NY, 10032. Phone: (212) 305-9382.
What is MELISSA ACCORDINO's NPI number?
MELISSA ACCORDINO's National Provider Identifier (NPI) is 1740422039, issued on 04/01/2009.
Does MELISSA ACCORDINO prescribe more brand-name or generic drugs?
MELISSA ACCORDINO's prescribing is 7% brand-name and 93% generic drugs by claim count, with $344K in brand drug costs.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does MELISSA ACCORDINO prescribe most often?
Based on 2023 Medicare Part D data, MELISSA ACCORDINO's most frequently prescribed drugs include Anastrozole, Exemestane, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MELISSA ACCORDINO accept Medicare?
MELISSA ACCORDINO appears in CMS Medicare data with 280 Part D claims and 83 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MELISSA ACCORDINO's credentials?
MELISSA ACCORDINO's NPI is 1740422039. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology